A previous publication from this lab (Patrick, et al. Bioorg. Med. Chem. 2016, 24 , 2451 - 2465 ) explored the antitrypanosomal activities of novel derivatives of 2-(2-benzamido)ethyl-4-phenylthiazole (1), which had been identified as a hit against Trypanosoma brucei, the causative agent of human African trypanosomiasis. While a number of these compounds, particularly the urea analogues, were quite potent, these molecules as a whole exhibited poor metabolic stability. The present work describes the synthesis of 65 new analogues arising from medicinal chemistry optimization at different sites on the molecule. The most promising compounds were the urea derivatives of 2-aryl-benzothiazol-5-amines. One such analogue, (S)-2-(3,4-difluorophenyl)-5-(3-fluoro-N-pyrrolidylamido)benzothiazole (57) was chosen for in vivo efficacy studies based upon in vitro activity, metabolic stability, and brain penetration. This compound attained 5/5 cures in murine models of both early and late stage human African trypanosomiasis, representing a new lead for the development of drugs to combat this neglected disease.
A previous publication from this lab (Patrick, et al. Bioorg. Med. Chem. 2016, 24 , 2451 - 2465 ) explored the antitrypanosomal activities of novel derivatives of 2-(2-benzamido)ethyl-4-phenylthiazole (1), which had been identified as a hit against n class="Species">Trypanosoma brucei, the causative agent of human African trypanosomiasis. While a number of these compounds, particularly the urea analogues, were quite potent, these molecules as a whole exhibited poor metabolic stability. The present work describes the synthesis of 65 new analogues arising from medicinal chemistry optimization at different sites on the molecule. The most promising compounds were the urea derivatives of 2-aryl-benzothiazol-5-amines. One such analogue, (S)-2-(3,4-difluorophenyl)-5-(3-fluoro-N-pyrrolidylamido)benzothiazole (57) was chosen for in vivo efficacy studies based upon in vitro activity, metabolic stability, and brain penetration. This compound attained 5/5 cures in murine models of both early and late stage human African trypanosomiasis, representing a new lead for the development of drugs to combat this neglected disease.
Authors: Sayaka Shibata; J Robert Gillespie; Angela M Kelley; Alberto J Napuli; Zhongsheng Zhang; Kuzma V Kovzun; Ranae M Pefley; Jocelyn Lam; Frank H Zucker; Wesley C Van Voorhis; Ethan A Merritt; Wim G J Hol; Christophe L M J Verlinde; Erkang Fan; Frederick S Buckner Journal: Antimicrob Agents Chemother Date: 2011-01-31 Impact factor: 5.191
Authors: Hari Babu Tatipaka; J Robert Gillespie; Arnab K Chatterjee; Neil R Norcross; Matthew A Hulverson; Ranae M Ranade; Pendem Nagendar; Sharon A Creason; Joshua McQueen; Nicole A Duster; Advait Nagle; Frantisek Supek; Valentina Molteni; Tanja Wenzler; Reto Brun; Richard Glynne; Frederick S Buckner; Michael H Gelb Journal: J Med Chem Date: 2014-01-15 Impact factor: 7.446
Authors: Stephanie Russell; Raphaël Rahmani; Amy J Jones; Harriet L Newson; Kevin Neilde; Ignacio Cotillo; Marzieh Rahmani Khajouei; Lori Ferrins; Sana Qureishi; Nghi Nguyen; Maria S Martinez-Martinez; Donald F Weaver; Marcel Kaiser; Jennifer Riley; John Thomas; Manu De Rycker; Kevin D Read; Gavin R Flematti; Eileen Ryan; Scott Tanghe; Ana Rodriguez; Susan A Charman; Albane Kessler; Vicky M Avery; Jonathan B Baell; Matthew J Piggott Journal: J Med Chem Date: 2016-09-19 Impact factor: 7.446
Authors: John H Ansede; Mariappan Anbazhagan; Reto Brun; Judy D Easterbrook; James Edwin Hall; David W Boykin Journal: J Med Chem Date: 2004-08-12 Impact factor: 7.446
Authors: Els Torreele; Bernadette Bourdin Trunz; David Tweats; Marcel Kaiser; Reto Brun; Guy Mazué; Michael A Bray; Bernard Pécoul Journal: PLoS Negl Trop Dis Date: 2010-12-21
Authors: Robert T Jacobs; Bakela Nare; Stephen A Wring; Matthew D Orr; Daitao Chen; Jessica M Sligar; Matthew X Jenks; Robert A Noe; Tana S Bowling; Luke T Mercer; Cindy Rewerts; Eric Gaukel; Jennifer Owens; Robin Parham; Ryan Randolph; Beth Beaudet; Cyrus J Bacchi; Nigel Yarlett; Jacob J Plattner; Yvonne Freund; Charles Ding; Tsutomu Akama; Y-K Zhang; Reto Brun; Marcel Kaiser; Ivan Scandale; Robert Don Journal: PLoS Negl Trop Dis Date: 2011-06-28
Authors: Melissa L Sykes; Jonathan B Baell; Marcel Kaiser; Eric Chatelain; Sarah R Moawad; Danny Ganame; Jean-Robert Ioset; Vicky M Avery Journal: PLoS Negl Trop Dis Date: 2012-11-29
Authors: Daniel G Silva; J Robert Gillespie; Ranae M Ranade; Zackary M Herbst; Uyen T T Nguyen; Frederick S Buckner; Carlos A Montanari; Michael H Gelb Journal: ACS Med Chem Lett Date: 2017-06-27 Impact factor: 4.345
Authors: Roberto I Cuevas-Hernández; Richard M B M Girard; Sarai Martínez-Cerón; Marcelo Santos da Silva; Maria Carolina Elias; Marcell Crispim; José G Trujillo-Ferrara; Ariel Mariano Silber Journal: Antimicrob Agents Chemother Date: 2020-01-27 Impact factor: 5.191
Authors: Amani S Awaad; Ahmed M Alafeefy; Fatmah A S Alasmary; Reham M El-Meligy; Saleh I Alqasoumi Journal: Saudi Pharm J Date: 2017-07-11 Impact factor: 4.330